AiViva Biopharma, Inc.
Developing Novel, Localized Treatments in Oncology, Ophthalmology, Dermatology, and Urology to Transform Patients' Lives
16 employees · est. 2015 · Costa Mesa, United States
Synaffix is the older company (2015 vs 2014); Synaffix is the larger of the two.
Side-by-Side Comparison
| Metric | AiViva Biopharma, Inc. | Synaffix |
|---|---|---|
| Founded | ||
| Founded | 2015 | 2014 older |
| Headquarters | ||
| Headquarters | Costa Mesa, United States | Oss, The Netherlands |
| Employees | ||
| Employees | 16 | 63 larger |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Acquired |
| Total Funding | ||
| Total Funding | Not tracked yet | $100.00M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 3 |
| Services | ||
| Services | Not tracked yet | ADC Platform Licensing, Bispecific Antibody Development, Targeted Therapy Development, Out-licensing Technology for Cancer Therapeutics |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical Companies, Biotechnology Firms, Oncology Researchers, Strategic Partners in Therapeutics |
| Taxonomy | ||
| Taxonomy | Biotech, Clinical Stage, Oncology, Ophthalmology, Dermatology, Urology, Localized Treatment, Targeted Therapy, Proprietary Technology, Pharmaceutical Development, Specialty Therapeutics, JEL™ Technology, Clinical Formulations, Drug Delivery, Unmet Medical Needs | Antibody-Drug Conjugates, ADC Technology Platform, Licensed Partnerships, Biotech Innovation, Clinical-Stage Development, Enzymatic Glycan Modification, Metal-Free Click Chemistry, Site-Specific Conjugation, Cancer Therapeutics, Immune Cell Engagers, Targeted Gene Therapy, Bispecific Antibodies, Patent Portfolio, Phase 1 Clinical Trials, High Growth Market Segments |
| Website | ||
| Website | aiviva.com | synaffix.com |
About AiViva Biopharma, Inc.
AiViva Biopharma, Inc. is a clinical stage biotech startup focused on developing groundbreaking technologies in the fields of oncology, ophthalmology, dermatology, and urology. Founded in 2016, the company aims to revolutionize existing treatments by creating localized and targeted therapies, while...
About Synaffix
Synaffix, a Lonza Company, is a pioneering biotech firm founded in 2014 and headquartered in The Netherlands. It boasts a proprietary, clinical-stage technology platform focused on antibody-drug conjugates (ADCs), renowned for optimizing safety and efficacy. The platform's value is underscored by m...
We will tell you when either one moves
BounceWatch watches AiViva Biopharma, Inc. and Synaffix for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at AiViva Biopharma, Inc. and Synaffix — by email.
Frequently Asked Questions
Compare AiViva Biopharma, Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at AiViva Biopharma, Inc. on 14 Sep 2024, and Synaffix on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.